About Us
Company Overview
Sansanima is an R&D-driven company originating from the University of Sheffield, dedicated to replacing animal testing in the world’s most vital biologics. Founded on NC3Rs-backed research in collaboration with the UK Medicines and Healthcare products Regulatory Agency (MHRA), our team has developed cutting-edge cell-based assay platforms that faithfully replicate the physiological intoxication mechanisms of tetanus and botulinum toxins, delivering specificity and sensitivity beyond what traditional animal models can achieve.
We are backed by Cambridge Angels and Sheffield Angels, and work closely with manufacturers and regulators to ensure our solutions are practical, reliable, and ready for use at scale. Our mission is to deliver technologies that are not only ethically transformative but also scientifically superior, establishing Sansanima as a trusted partner in shaping the future of biologics.
Company Values & Vision
Our vision is to enable the global replacement of animal testing for the world’s most vital biologics. At Sansanima, we unite scientific excellence with ethical responsibility to redefine how biologics are tested, validated, and developed.
Excellence in Science
Ethical Innovation
Collaborative Partnerships
Scalable & Sustainable
Regulatory alignment
Partnerships & Collaborations
We develop our technologies both on an industry-wide level as well as providing bespoke solutions for individual Clostridial manufacturers. By partnering with Sansanima Ltd, you’ll gain access to cutting-edge in vitro assay systems tailored to your specific needs, backed by our scientific expertise and commitment to innovation.
Whether you’re seeking to enhance product safety, meet regulatory standards, or reduce reliance on animal testing, we are ready to collaborate and co-develop transformative solutions with you.
